The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Transmedics Group Inc shares valued at $1,167,147 were sold by Hassanein Waleed H on May 15 ’24. At $135.32 per share, Hassanein Waleed H sold 8,625 shares. The insider’s holdings dropped to 61,643 shares worth approximately $8.41 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Weill David sold 2,500 shares, netting a total of over 324,550 in proceeds. Following the sale of shares at $129.82 each, the insider now holds 11,193 shares.
Before that, Basile Edward M had sold 7,157 shares from its account. In a trade valued at $930,278, the Director traded Transmedics Group Inc shares for $129.98 each. Upon closing the transaction, the insider’s holdings decreased to 7,157 shares, worth approximately $0.16 million.
As published in their initiating research note from Piper Sandler on March 28, 2024, Transmedics Group Inc [TMDX] has been an Overweight and the price target has been revised to $95. Analysts at Robert W. Baird started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid July. As of August 02, 2022, JP Morgan has increased its “Neutral” rating to a “an Overweight” for TMDX. Earlier on October 08, 2020, JP Morgan downgraded its rating. Their new recommendation was “a Neutral” for TMDX stock which previously was a “an Overweight”.
Analyzing TMDX Stock Performance
During the last five days, there has been a drop of approximately -0.40%. Over the course of the year, Transmedics Group Inc shares have jumped approximately 72.84%. Shares of the company reached a 52-week high of $144.23 on 05/30/24 and a 52-week low of $69.43 on 03/25/24. A 50-day SMA is recorded $104.95, while a 200-day SMA reached $77.87. Nevertheless, trading volume fell to 0.94 million shares from 0.72 million shares the previous day.
Support And Resistance Levels for Transmedics Group Inc (TMDX)
According to the 24-hour chart, there is a support level at 132.21, which, if violated, would cause prices to drop to 127.99. In the upper region, resistance lies at 142.43. The next price resistance is at 148.44. RSI (Relative Strength Index) is 65.62 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.60, which suggests the price will increase in the coming days. Percent R is at 48.55%, indicating low price movement. Stochastics %K at selling indicates that the stock is to be held.
